Table 3 Effect of initial serum AHSG level on the survival of patients with alcoholic liver cirrhosis throughout the 1-year observation period (A) and between months 1–12 (B)
A | ||||
|---|---|---|---|---|
Deceased | Survived | Total | Mortality rate % | |
Serum AHSG < 365 μg/ml | 32 | 3 | 35 | 94.1 |
Serum AHSG ≥ 365 μg/ml | 5 | 49 | 54 | 9.3 |
Total | 37 | 52 | 89 | |
p < 0.001, Relative Risk: 9.874 (95% C.I.: 4.258 – 22.898) | ||||
B | ||||
Deceased | Survived | Total | Mortality rate % | |
Serum AHSG < 365 μg/ml | 18 | 3 | 21 | 85.7 |
Serum AHSG ≥ 365 μg/ml | 5 | 49 | 54 | 9.3 |
Total | 23 | 52 | 75 | |
p < 0.001, Relative Risk: 9.257 (95% C.I.: 3.945 – 21.724) | ||||